Literature DB >> 6977135

SLE syndrome, probably induced by labetalol.

R C Brown, J Cooke, M S Losowsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6977135      PMCID: PMC2424855          DOI: 10.1136/pgmj.57.665.189

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Case report. Propranolol-induced lupus syndrome?

Authors:  T Harrison; T S Sisca; W H Wood
Journal:  Postgrad Med       Date:  1976-01       Impact factor: 3.840

2.  Systemic lupus erythematosus syndrome induced by pindolol.

Authors:  J Bensaid; J C Aldigier; N Gualde
Journal:  Br Med J       Date:  1979-06-16

3.  Lupus-type illness associated with labetalol.

Authors:  I D Griffiths; J Richardson
Journal:  Br Med J       Date:  1979-08-25

Review 4.  Antinuclear antibodies and cardiovascular drugs.

Authors:  J D Wilson
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

5.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
  5 in total
  3 in total

1.  Betaxolol and drug-induced lupus complicated by pericarditis and large pericardial effusion.

Authors:  J T Hardee; C A Roldan; T W Du Clos
Journal:  West J Med       Date:  1997-08

Review 2.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

Review 3.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.